Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitor

By Kanamori S.   Nishimura Y.   Okuno Y.   Horii N.   Saga T.   Hiraoka M.  

International Journal of Hyperthermia, Vol. 15, Iss. 4, 1999-07 ,pp. : 267-278

Informa Healthcare

Access to resources Recommend Favorite

The pivotal role of VEGF in tumor angiogenesis: Molecular facts and therapeutic opportunities

By Siemeister G.   Martiny-Baron G.   Marmé D.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 2, 1998-06 ,pp. : 241-248

Springer Publishing Company

Access to resources Recommend Favorite

Targeting Vascular Endothelial Growth Factor (VEGF) for Anti-tumor Therapy, by Anti-VEGF Neutralizing Monoclonal Antibodies or by VEGF Receptor Tyrosine-kinase Inhibitors

By Schlaeppi J-M.  

Cancer and Metastasis Reviews, Vol. 18, Iss. 4, 1999-12 ,pp. : 473-481

Springer Publishing Company

Access to resources Recommend Favorite

Impact of acetylsalicylic acid on tumor angiogenesis and lymphangiogenesis through inhibition of VEGF signaling in a murine sarcoma model

By              

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1907-1913

Spandidos Publications

Access to resources Recommend Favorite

Immunohistochemical study on VEGF expression in endometrial carcinoma – comparison with p53 expression, angiogenesis, and tumor histologic grade

By Fujisawa T.   Watanabe J.   Akaboshi M.   Ohno E.   Kuramoto H.  

Journal of Cancer Research and Clinical Oncology, Vol. 127, Iss. 11, 2001-11 ,pp. : 668-674

Springer Publishing Company

Access to resources Recommend Favorite